Results 151 to 160 of about 5,459 (165)

N-Acetyl-leucine in progressive CACNA1A ataxia: A case series

open access: yesEuropean Journal of Paediatric Neurology
Background: CACNA1A-related disorders are rare and progressive; to date, there is no approved treatment. Trials with N-acetyl-leucine (NAL) demonstrated efficacy in disorders featuring ataxia, cognitive impairment, and epilepsy.
Argirios Dinopoulos   +2 more
exaly   +2 more sources

CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients

European Journal of Paediatric Neurology, 2021
Laurent Villard   +2 more
exaly  

The complexities of CACNA1A in clinical neurogenetics

Journal of Neurology, 2021
Maartje Pennings   +2 more
exaly  

Instrumented gait analysis defines the walking signature of CACNA1A disorders

Journal of Neurology, 2021
Gregor Wenning   +2 more
exaly  

Seizure response to carbamazepine in a patient with CACNA1A-associated epilepsy: A case report

Seizure: the Journal of the British Epilepsy Association, 2023
Paolo Solla, Francesca Pinna
exaly  

Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population

Seizure: the Journal of the British Epilepsy Association, 2015
Lili Long, Bo Xiao, Hongyu Long
exaly  

Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia

European Journal of Paediatric Neurology, 2017
Massimiliano Valeriani   +2 more
exaly  

Recurrence of the T666M Calcium Channel CACNA1A Gene Mutation in Familial Hemiplegic Migraine with Progressive Cerebellar Ataxia

American Journal of Human Genetics, 1999
Anne Ducros   +2 more
exaly  

Home - About - Disclaimer - Privacy